Nonalcoholic Steatohepatitis (NASH) Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
According to 99Strategy, the Global Nonalcoholic Steatohepatitis (NASH) Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Nonalcoholic Steatohepatitis (NASH) market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
- Asia Pacific
- North America
- Europe
- South America
- Middle East & Africa
- Boehringer Ingelheim
- Cerenis Therapeutics
- Connexios Life Sciences
- Genfit
- Islet Sciences
- Nimbus Therapeutics
- Verva Pharmaceuticals
- Viking Therapeutics
- Astazeneca Plc
- Galmed Pharmaceuticals
- GENFIT SA
- Gilead Science
- Novo Nordisk
- Immuron
- Intercepts Pharmaceuticals
- Enzo Biochem
- Tobira Therapeutics
- Weight Loss Treatment
- Insulin-Sensitizing Agents
- Lipid-Lowering Drugs
- Antioxidants
- Others
- Hospitals
- Clinics
- Research Institute
- Others
- Overview of the Nonalcoholic Steatohepatitis (NASH) market including production, consumption, status & forecast and market growth
- 2015-2018 historical data and 2019-2025 market forecast
- Geographical analysis including major countries
- Overview the product type market including development
- Overview the end-user market including development
1 INDUSTRIAL CHAIN OVERVIEW
1.1 Nonalcoholic Steatohepatitis (NASH) Industry
1.1.1 Overview
1.1.2 Characteristics of Nonalcoholic Steatohepatitis (NASH)
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Weight Loss Treatment
1.3.2 Insulin-Sensitizing Agents
1.3.3 Lipid-Lowering Drugs
1.3.4 Antioxidants
1.3.5 Others
1.4 End-Use List
1.4.1 Demand in Hospitals
1.4.2 Demand in Clinics
1.4.3 Demand in Research Institute
1.4.4 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2015-2025
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 Boehringer Ingelheim Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Cerenis Therapeutics Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Connexios Life Sciences Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Genfit Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Islet Sciences Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Nimbus Therapeutics Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Verva Pharmaceuticals Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Viking Therapeutics Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Astazeneca Plc Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Galmed Pharmaceuticals Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 GENFIT SA Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Gilead Science Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Novo Nordisk Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Immuron Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Intercepts Pharmaceuticals Overview
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Enzo Biochem Overview
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Tobira Therapeutics Overview
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Product Type
5.2.1 Market in Weight Loss Treatment
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Insulin-Sensitizing Agents
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Lipid-Lowering Drugs
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Antioxidants
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
5.2.5.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospitals
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Clinics
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Research Institute
6.2.3.1 Market Size
6.2.3.2 Situation & Development
6.2.4 Market in Others
6.2.4.1 Market Size
6.2.4.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast
7.2.2 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
10 RESEARCH CONCLUSION
1.1 Nonalcoholic Steatohepatitis (NASH) Industry
1.1.1 Overview
1.1.2 Characteristics of Nonalcoholic Steatohepatitis (NASH)
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Weight Loss Treatment
1.3.2 Insulin-Sensitizing Agents
1.3.3 Lipid-Lowering Drugs
1.3.4 Antioxidants
1.3.5 Others
1.4 End-Use List
1.4.1 Demand in Hospitals
1.4.2 Demand in Clinics
1.4.3 Demand in Research Institute
1.4.4 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2015-2025
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 Boehringer Ingelheim Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Cerenis Therapeutics Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Connexios Life Sciences Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Genfit Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Islet Sciences Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Nimbus Therapeutics Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Verva Pharmaceuticals Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Viking Therapeutics Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Astazeneca Plc Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Galmed Pharmaceuticals Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 GENFIT SA Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Gilead Science Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Novo Nordisk Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Immuron Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Intercepts Pharmaceuticals Overview
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Enzo Biochem Overview
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Tobira Therapeutics Overview
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Product Type
5.2.1 Market in Weight Loss Treatment
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Insulin-Sensitizing Agents
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Lipid-Lowering Drugs
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Antioxidants
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
5.2.5.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospitals
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Clinics
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Research Institute
6.2.3.1 Market Size
6.2.3.2 Situation & Development
6.2.4 Market in Others
6.2.4.1 Market Size
6.2.4.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast
7.2.2 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
10 RESEARCH CONCLUSION
LIST OF TABLES
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Boehringer Ingelheim Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cerenis Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Cerenis Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Connexios Life Sciences Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Connexios Life Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Genfit Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Genfit (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Islet Sciences Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Islet Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Nimbus Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Nimbus Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Verva Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Verva Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Viking Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Viking Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Astazeneca Plc Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Astazeneca Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Galmed Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Galmed Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table GENFIT SA Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of GENFIT SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Gilead Science Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Gilead Science (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Novo Nordisk (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Immuron Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Immuron (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Intercepts Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Intercepts Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Enzo Biochem Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Enzo Biochem (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Tobira Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Tobira Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Boehringer Ingelheim Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cerenis Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Cerenis Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Connexios Life Sciences Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Connexios Life Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Genfit Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Genfit (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Islet Sciences Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Islet Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Nimbus Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Nimbus Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Verva Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Verva Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Viking Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Viking Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Astazeneca Plc Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Astazeneca Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Galmed Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Galmed Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table GENFIT SA Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of GENFIT SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Gilead Science Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Gilead Science (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Novo Nordisk (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Immuron Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Immuron (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Intercepts Pharmaceuticals Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Intercepts Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Enzo Biochem Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Enzo Biochem (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Tobira Therapeutics Overview List
Table Nonalcoholic Steatohepatitis (NASH) Business Operation of Tobira Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
LIST OF FIGURES
Figure Nonalcoholic Steatohepatitis (NASH) Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Weight Loss Treatment, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Weight Loss Treatment, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Insulin-Sensitizing Agents, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Insulin-Sensitizing Agents, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Lipid-Lowering Drugs, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Lipid-Lowering Drugs, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Antioxidants, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Antioxidants, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Research Institute, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Research Institute, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Nonalcoholic Steatohepatitis (NASH) Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Weight Loss Treatment, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Weight Loss Treatment, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Insulin-Sensitizing Agents, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Insulin-Sensitizing Agents, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Lipid-Lowering Drugs, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Lipid-Lowering Drugs, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Antioxidants, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Antioxidants, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Research Institute, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Research Institute, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
